High-purity lyophilized injectables optimized for British clinical standards, strict temperature-controlled storage, and seamless distribution across the UK market.
Deep insight into the United Kingdom's evolving therapeutic landscape for metabolic health, obesity care, and pharmaceutical peptide supply chain infrastructure.
The United Kingdom represents one of the fastest-growing European markets for GLP-1 (Glucagon-Like Peptide-1), dual GIP/GLP-1, and next-generation triple agonist (GLP-1/GIP/Glucagon) receptor therapies. Driven by the National Health Service (NHS) weight management initiatives, NICE regulatory approvals, and an expanding private healthcare sector across London, Manchester, and Edinburgh, demand for stable, high-purity finished dosage forms (FDF) has reached an unprecedented scale.
Navigating the post-Brexit regulatory terrain requires strict adherence to the Medicines and Healthcare products Regulatory Agency (MHRA) protocols, Good Manufacturing Practice (cGMP), and Qualified Person (QP) release procedures. Our finished peptides undergo stringent high-performance liquid chromatography (HPLC) mass spectrometry analysis, endotoxin screening, and stability testing to ensure full compliance for British pharmaceutical distributors, research centers, and healthcare networks.
Engineered with state-of-the-art Solid-Phase Peptide Synthesis (SPPS) and vacuum freeze-drying to preserve maximum biological activity and long-term shelf stability.
Utilizing optimized primary and secondary drying cycles, our finished vials achieve residual moisture levels strictly under 1.0%. This prevents peptide degradation through hydrolysis and ensures immediate reconstitution with Bacteriostatic Water or Sterile Water for Injection.
Formulated with pharmaceutical-grade mannitol or trehalose excipient matrices. The uniform, white lyophilized cake offers high mechanical strength against transit vibration during global air freight into major UK entry hubs (Heathrow, Gatwick, Manchester).
Class A laminar flow cleanroom filling under ISO 14644-1 standards. Vials are sealed with bromobutyl rubber stoppers and flip-off aluminum caps, providing absolute protection against oxygen intrusion and humidity exposure.
| Parameters | Tirzepatide Injectable | Semaglutide Injectable | Retatrutide Injectable | NAD+ Lyophilized Powder |
|---|---|---|---|---|
| Primary Mechanism | Dual GIP / GLP-1 Agonist | Mono GLP-1 Agonist | Triple GIP / GLP-1 / Glucagon | Cellular Energy / Coenzyme |
| Available Strengths | 10mg, 15mg, 20mg, 30mg, 60mg | 10mg, 15mg, 20mg, 30mg | 10mg, 20mg, 30mg | 500mg, 1000mg |
| Purity (HPLC) | ≥ 99.0% | ≥ 99.0% | ≥ 99.0% | ≥ 99.5% |
| Appearance | White Lyophilized Powder | White Lyophilized Powder | White Lyophilized Powder | White Crystal/Powder |
| Endotoxin (LAL Test) | < 0.05 EU/mg | < 0.05 EU/mg | < 0.05 EU/mg | Strictly Non-Pyrogenic |
| Reconstitution Time | < 30 Seconds | < 30 Seconds | < 30 Seconds | Instantaneous |
| Storage Protocol | 2-8°C (Refrigerated) / -20°C | 2-8°C (Refrigerated) / -20°C | 2-8°C (Refrigerated) / -20°C | Store in Cool Dry Place |
End-to-end support ranging from custom active pharmaceutical ingredient (API) synthesis to full contract manufacturing and supply chain management.
Scalable peptide synthesis from milligram research batches to multi-kilogram commercial production, tailored sequence modifications, and isotope labeling.
Turnkey Finished Dosage Form licensing solutions backed by full CTD Dossier paperwork, validation batches, and stability reports for quick market integration.
Technical consultation on setting up high-throughput lyophilization suites, analytical testing equipment, and cGMP compliance frameworks in Great Britain.
Validated express shipping utilizing temperature-monitored smart containers, ensuring uncompromised biological activity from factory floor to British destination hubs.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard enables flexible, scalable, and cost-effective solutions. Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Learn More & Inquire
Stay informed with the latest scientific breakthroughs, formulation technologies, and therapeutic developments in peptide APIs.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of TKPRPGP sequence, offering novel neuropharmacological potential...
Read Technical Article →
As a professional Thymosin Beta-4 API manufacturer, we provide high-grade peptide solutions for biotechnology research and pharmaceutical organizations...
Read Technical Article →
BPC-157 API is a synthetic pentadecapeptide investigated for tissue repair, gastrointestinal protection, and cellular integrity applications...
Read Technical Article →
With continuous developments in neuroactive peptides, Semax has gained strong attention for its structural stability and target specificity...
Read Technical Article →
SS-31 (Elamipretide) is a mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane and support cellular bioenergetics...
Read Technical Article →Tailored supply chain workflows designed specifically for UK compounding pharmacies, clinical trial networks, and private healthcare groups.
Alignment with client formulation criteria, analytical parameters (HPLC/MS), packaging format, and volume commitments.
Automated solid-phase synthesis, chromatographic purification, ultrafiltration, and aseptic freeze-drying cake formulation.
Exhaustive quality control testing including heavy metal assays, residual solvent analysis, sterility USP <71>, and endotoxin verification.
Temperature-monitored express air cargo directly to UK distribution hubs with complete custom clearance documentation.
Addressing essential technical, regulatory, and supply chain queries for buyers operating in the United Kingdom.
Every shipment is dispatched with a comprehensive Certificate of Analysis (CoA), including High-Performance Liquid Chromatography (HPLC) chromatograms, Mass Spectrometry (MS) identification, endotoxin assessment, and residual solvent reports. Batch production records and TSE/BSE-free statements are also supplied upon request.
We utilize validated temperature-controlled cold-chain packaging equipped with phase-change material (PCM) gel packs and insulated containers. Real-time GPS and temperature data loggers ensure that products remain between 2°C and 8°C (or -20°C for frozen APIs) throughout transit to London Heathrow or regional airports.
Yes. We offer contract manufacturing, custom vial dosing (e.g., 10mg, 15mg, 20mg, 30mg, 60mg), customized stopper colors, flip-off seal branding, and custom outer box packaging tailored to meet specific regulatory or branding demands of British healthcare clients.
We accommodate both flexible small-batch pilot validation runs for specialized clinical research facilities and multi-thousand vial commercial production batches for large pharmaceutical wholesalers and distribution networks across Great Britain.
Explore our extensive range of high-purity peptides, dual/triple agonist injectables, and cellular health products engineered for UK excellence.
Accelerate your market expansion with our cGMP-compliant manufacturing, high-purity dual and triple agonist peptide formulations, and validated cold-chain global logistics.